Literature DB >> 32243895

The regulatory functions of circular RNAs in osteosarcoma.

Negin Soghli1, Durdi Qujeq2, Tooba Yousefi3, Negar Soghli4.   

Abstract

Osteosarcoma (OS) is known as a malignant bone tumor affecting mainly children and younger adults. Despite all the improvements in the treatment of OS, the overall survival among patients remained mostly unsatisfied. It involves different mechanisms and signaling pathways. Some recent studies confirmed that circular RNAs (circRNAs) have a revelatory role in controlling OS cell proliferation, invasion, and metastasis. CircRNAs consist of a covalently closed-loop structure with neither 5' nor 3' poly adenylated tail, lacking protein-encoding ability formed by back-splicing mechanisms. They mainly act as microRNA (miRNA) sponges and modulate the downstream biological processes. Up/down regulation of some circRNAs demonstrated to serve as the oncogenic factor in some tumor tissues such as OS. In this article, we review the regulatory functions of circRNAs resulting in OS cell progression or restraint and the potential for being used in vitro or in vivo as diagnostic or therapeutic biomarkers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CircRNA; DNA; Osteosarcoma; ciRNA; ctDNA

Mesh:

Substances:

Year:  2020        PMID: 32243895     DOI: 10.1016/j.ygeno.2020.03.024

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.

Authors:  Rui Hu; Shan Chen; Jianxin Yan
Journal:  J Orthop Surg Res       Date:  2021-05-07       Impact factor: 2.359

Review 2.  Circular RNAs in osteoarthritis: indispensable regulators and novel strategies in clinical implications.

Authors:  Wenchao Zhang; Lin Qi; Ruiqi Chen; Jieyu He; Zhongyue Liu; Wanchun Wang; Chao Tu; Zhihong Li
Journal:  Arthritis Res Ther       Date:  2021-01-12       Impact factor: 5.156

3.  CircRNA hsa_circ_0005909 Promotes Cell Proliferation of Osteosarcoma Cells by Targeting miR-338-3p/HMGA1 Axis.

Authors:  Cailong Zhang; Na Na; Li Liu; Yingzhu Qiu
Journal:  Cancer Manag Res       Date:  2021-01-27       Impact factor: 3.989

4.  Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Authors:  Qi Shao; Yong Huang; Cai Zhang; Xiaochan Gao; Shiyang Gao
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

Review 5.  Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.

Authors:  Jingyu Zhong; Guangcheng Zhang; Weiwu Yao
Journal:  J Orthop Surg Res       Date:  2021-10-07       Impact factor: 2.359

6.  circATP2A2 promotes osteosarcoma progression by upregulating MYH9.

Authors:  Xin Cao; Xianfeng Meng; Peng Fu; Lin Wu; Zhen Yang; Huijin Chen
Journal:  Open Med (Wars)       Date:  2021-11-22

7.  Hsa_circ_0001017 promotes cell proliferation, migration and invasion in osteosarcoma by sponging miR-145-5p.

Authors:  Qinglei Yang; Hongying Yu; Konghe Hu
Journal:  J Orthop Surg Res       Date:  2022-03-28       Impact factor: 2.359

8.  circSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network.

Authors:  Hepeng Zhang; Fanyu Meng; Shuaicheng Dong
Journal:  Biomed Res Int       Date:  2020-09-27       Impact factor: 3.411

9.  Circular RNA hsa_circ_0069117 suppresses proliferation and migration of osteosarcoma cells lines via miR-875-3p/PF4V1 axis.

Authors:  Ziyan Zhang; Lin Zhou; Shicheng Zhou; Xin Li
Journal:  J Orthop Surg Res       Date:  2022-01-21       Impact factor: 2.359

10.  CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis.

Authors:  Shenglong Li; Fei Liu; Ke Zheng; Wei Wang; Enduo Qiu; Yi Pei; Shuang Wang; Jiaming Zhang; Xiaojing Zhang
Journal:  Mol Cancer       Date:  2021-12-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.